{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:22:15Z","timestamp":1770502935777,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,9,1]]},"DOI":"10.1038\/sj.leu.2401892","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:37:20Z","timestamp":1031164640000},"page":"1577-1582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy"],"prefix":"10.1038","volume":"14","author":[{"given":"MA","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Maslak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Noy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Zelenetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DA","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DW","family":"Golde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,8,31]]},"reference":[{"key":"BF2401892_CR1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood.V78.8.1901.1901","volume":"78","author":"G Dighiero","year":"1991","unstructured":"Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet J-L and the French Cooperative Group on CLL . B-cell chronic lymphocytic leukemia: present status and future directions Blood 1991 78: 1901\u20131914","journal-title":"Blood"},{"key":"BF2401892_CR2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V85.2.307.307","volume":"85","author":"S O\u2019Brien","year":"1995","unstructured":"O\u2019Brien S, del Giglio A, Keating M . Advances in the biology and treatment of B-cell chronic lymphocytic leukemia Blood 1995 85: 307\u2013318","journal-title":"Blood"},{"key":"BF2401892_CR3","first-page":"457","volume":"30","author":"MR Grever","year":"1988","unstructured":"Grever MR, Kopecky KJ, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley R, Von Hoff DD, Balcerzak SP . Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia Nouv Rev Fr Hematol 1988 30: 457\u2013459","journal-title":"Nouv Rev Fr Hematol"},{"key":"BF2401892_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood.V74.1.19.19","volume":"74","author":"MJ Keating","year":"1989","unstructured":"Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie KB . Fludarabine: a new agent with major activity against chronic lymphocytic leukemia Blood 1989 74: 19\u201325","journal-title":"Blood"},{"key":"BF2401892_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1200\/JCO.1993.11.4.679","volume":"11","author":"G Juliusson","year":"1993","unstructured":"Juliusson G, Liliemark J . High complete remission rate from 2-chloro-2\u2032-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count J Clin Oncol 1993 11: 679\u2013689","journal-title":"J Clin Oncol"},{"key":"BF2401892_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1995.13.3.570","volume":"13","author":"A Saven","year":"1995","unstructured":"Saven A, Leman RH, Kosty M, Beutler E, Piro LD . 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia J Clin Oncol 1995 13: 570\u2013574","journal-title":"J Clin Oncol"},{"key":"BF2401892_CR7","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1200\/JCO.1985.3.9.1196","volume":"3","author":"MR Grever","year":"1985","unstructured":"Grever MR, Leiby JM, Kraut EH, Wilson HE, Neidhart JA, Wall RL, Balcerzak SP . Low-dose deoxycoformycin in lymphoid malignancy J Clin Oncol 1985 3: 1196\u20131201","journal-title":"J Clin Oncol"},{"key":"BF2401892_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1989.7.4.433","volume":"7","author":"RO Dillman","year":"1989","unstructured":"Dillman RO, Mick R, Ross McIntyre OR . Pentostatin in chronic lymphocytic leukemia: a phase II trial of cancer and leukemia Group B J Clin Oncol 1989 7: 433\u2013438","journal-title":"J Clin Oncol"},{"key":"BF2401892_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1200\/JCO.1991.9.1.44","volume":"9","author":"MJ Keating","year":"1991","unstructured":"Keating MJ, Kantarjian H, O\u2019Brien S, Koller C, Talpaz M, Schachner J, Childs CC, Freireich EJ, McCredie KB . Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia J Clin Oncol 1991 9: 44\u201349","journal-title":"J Clin Oncol"},{"key":"BF2401892_CR10","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V81.11.2878.2878","volume":"81","author":"MJ Keating","year":"1993","unstructured":"Keating MJ, O\u2019Brien S, Kantarjian H, Plunkett W, Estey E, Killer C, Beran M, Freireich EJ . Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent Blood 1993 81: 2878\u20132884","journal-title":"Blood"},{"key":"BF2401892_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.7326\/0003-4819-117-6-466","volume":"117","author":"E Anaissie","year":"1992","unstructured":"Anaissie E, Kontoyiannis DP, Kantarjian H, Elting L, Robertson LE, Keating M . Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone Ann Intern Med 1992 117: 466\u2013469","journal-title":"Ann Intern Med"},{"key":"BF2401892_CR12","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood.V82.6.1695.1695","volume":"82","author":"S O\u2019Brien","year":"1993","unstructured":"O\u2019Brien S, Kantarjian H, Beran M, Smith T, Koller C, Estey E, Robertson LE, Lerner S, Keating M . Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment Blood 1993 82: 1695\u20131700","journal-title":"Blood"},{"key":"BF2401892_CR13","first-page":"361","volume":"7","author":"L Elias","year":"1993","unstructured":"Elias L, Stock-Novack D, Head DR, Grever MR, Weick JK, Chapman RA, Godwin JE, Metz EN, Appelbaum FR . A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study Leukemia 1993 7: 361\u2013365","journal-title":"Leukemia"},{"key":"BF2401892_CR14","first-page":"1290","volume":"8","author":"M Weiss","year":"1994","unstructured":"Weiss M, Spiess T, Berman E, Kempin S . Concomitant administration of chlorambucil limits dose intensity of fludarabine inpreviously treated patients with chronic lymphocytic leukemia Leukemia 1994 8: 1290\u20131293","journal-title":"Leukemia"},{"key":"BF2401892_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ajh.2830290307","volume":"29","author":"BD Cheson","year":"1988","unstructured":"Cheson BD, Bennett JM, Rai KR, Grever M, Kay N, Schiffer C, Oken M, Keating M, Boldt D, Kempin S, Foon K . Guidelines for clinical protocols for chronic lymphocytic leukemia: report of the NCI-Sponsored Working Group Am J Hematol 1988 29: 152\u2013163","journal-title":"Am J Hematol"},{"key":"BF2401892_CR16","first-page":"359","volume":"30","author":"E Montserrat","year":"1988","unstructured":"Montserrat E, Vinolas N, Reverter JC, Rozman C . Natural history of chronic lymphocytic leukemia: on the progression and prognosis of early clinical stages Nouv Rev Fr Hematol 1988 30: 359\u2013361","journal-title":"Nouv Rev Fr Hematol"},{"key":"BF2401892_CR17","unstructured":"Noy A, Verma R, Glenn M, Maslak P, Rahman Z, Keenan J, Weiss M, Zelenetz A . Clonotypic PCR confirms minimal residual disease (MRD) in CLL nodular PR: Preliminary results from a sequential treatment CLL protocol Blood (submitted)"},{"key":"BF2401892_CR18","volume-title":"Common Toxicity Criteria","author":"Institute National Cancer","year":"1988","unstructured":"National Cancer Institute, Division of Cancer Treatment . Common Toxicity Criteria Bethesda, MD 1988"},{"key":"BF2401892_CR19","first-page":"141a","volume":"88","author":"KR Rai","year":"1996","unstructured":"Rai KR, Peterson B, Elias L, Shepherd L, Hines J, Nelson D, Cheson B, Kolitz J, Schiffer C . A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG\/NCI-C and ECOG Inter-group study Blood 1996 88: 141a","journal-title":"Blood"},{"key":"BF2401892_CR20","doi-asserted-by":"crossref","first-page":"607a","DOI":"10.1182\/blood.V86.2.607.bloodjournal862607","volume":"86","author":"KR Rai","year":"1995","unstructured":"Rai KR, Peterson B, Kolitz J, Elias L, Shepherd J, Hines J, Cheson B, Schiffer C . Fludarabine induces a high complete remission rate in previously untreated patients with active chronic lymphocytic leukemia. A randomized inter-group study Blood 1995 86: 607a","journal-title":"Blood"},{"key":"BF2401892_CR21","first-page":"480a","volume":"88","author":"S O\u2019Brien","year":"1996","unstructured":"O\u2019Brien S, Kantarjian H, Beran M, Freireich E, Kornblau S, Killer C, Lerner S, Gilbreath J, Keating M . Fludarabine (FAMP) and cyclophosphamide (CTX) therapy in chronic lymphocytic leukemia (CLL) Blood 1996 88: 480a","journal-title":"Blood"},{"key":"BF2401892_CR22","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","volume":"87","author":"BD Cheson","year":"1996","unstructured":"Cheson BD, Bennett JM, Grever M, Kay N, Keating M, O\u2019Brien S, Rai K . National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment Blood 1996 87: 4990\u20134997","journal-title":"Blood"},{"key":"BF2401892_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V80.1.29.29","volume":"80","author":"LE Robertson","year":"1992","unstructured":"Robertson LE, Huh YO, Butler JJ, Pugh W, Hirsch-Ginsburg C, Stass S, Kantarjian H, Keating M . Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, immunophenotypic, and molecular analysis Blood 1992 80: 29\u201336","journal-title":"Blood"},{"key":"BF2401892_CR24","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/S0140-6736(96)91681-5","volume":"347","author":"S Johnson","year":"1996","unstructured":"Johnson S, Smith AG, Loffler H, Osby E, Juliusson G, Emmerich B, Wyld P, Hiddemann W . Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia Lancet 1996 347: 1432\u20131438","journal-title":"Lancet"},{"key":"BF2401892_CR25","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199805213382104","volume":"338","author":"G Dighiero","year":"1998","unstructured":"Dighiero G, Maloum K, Desablens B, Cazin B, Navarro M, Leblay R, Leporier M, Jaubert J, Lepeu G, Dreyfus B, Binet J, Travade P . Chlorambucil in indolent chronic lymphocytic leukemia New Engl J Med 1998 338: 1506\u20131514","journal-title":"New Engl J Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401892","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:44:46Z","timestamp":1648763086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,31]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9,1]]}},"alternative-id":["BF2401892"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401892","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8,31]]},"assertion":[{"value":"8 March 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}